Estados financieros detallados de Quantum-Si incorporated (QSI): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 35.0%, margen operativo -59.3%, margen neto -61.4%.
Al precio actual de $0.73, QSI presenta beneficios negativos (P/E no significativo) y un ROE del -47.12%. La capitalización bursátil es de $144M.
Cuenta de Resultados (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | $1.1M | $3.1M | $2.4M |
| Coste de Ventas | 0 | 0 | 0 | 0 | $594000 | $1.5M | $1.3M |
| Beneficio Bruto | 0 | 0 | 0 | 0 | $488000 | $1.6M | $1.2M |
| I+D | $28.1M | $27.6M | $46.6M | $72.1M | $67.0M | $59.6M | $53.8M |
| Generales y Administrativos | $8.5M | $9.1M | $50.3M | $42.3M | $44.6M | $50.5M | $44.8M |
| Gastos Operativos | $36.6M | $36.7M | $96.9M | $123.8M | $111.7M | $110.2M | $98.5M |
| Beneficio Operativo | -$36.6M | -$36.7M | -$96.9M | -$123.8M | -$111.2M | -$108.6M | -$97.4M |
| EBITDA | -$35.8M | -$35.8M | -$93.9M | -$111.8M | -$91.8M | -$96.4M | -$92.9M |
| Gastos por Intereses | 0 | $9000 | $5000 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$35.8M | -$36.6M | -$95.0M | -$132.4M | -$96.0M | -$101.0M | -$101.3M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | $56000 | $58000 |
| Beneficio Neto | -$35.8M | -$36.6M | -$95.0M | -$132.4M | -$96.0M | -$101.0M | -$101.3M |
| BPA | $-0.26 | $-6.81 | $-1.19 | $-0.95 | $-0.68 | $-0.71 | $-0.51 |
| BPA Diluido | $-0.26 | $-6.81 | $-1.19 | $-0.95 | $-0.68 | $-0.71 | $-0.51 |
| Acciones en Circulación (Diluidas) | $136.4M | $5.4M | $79.6M | $139.3M | $141.3M | $143.2M | $197.8M |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $32.9M | $36.9M | $35.8M | $84.3M | $133.9M | $49.2M | $21.6M |
| Inversiones a Corto | 0 | 0 | $435.5M | $267.0M | $123.9M | $160.4M | $141.3M |
| Cuentas por Cobrar | 0 | 0 | $872000 | 0 | $368000 | $1.3M | $561000 |
| Inventario | 0 | 0 | 0 | 0 | $3.9M | $4.1M | $3.2M |
| Activos Corrientes | $33.9M | $37.9M | $477.2M | $358.2M | $266.3M | $218.0M | $175.9M |
| Inmovilizado Material | $2.6M | $2.0M | $15.9M | $32.6M | $30.7M | $29.1M | $16.7M |
| Fondo de Comercio | 0 | 0 | $9.5M | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | $532000 | 0 | 0 |
| Activos Totales | $37.4M | $40.6M | $503.2M | $391.5M | $298.2M | $247.9M | $245.6M |
| Cuentas por Pagar | $869000 | $1.3M | $3.4M | $3.9M | $1.8M | $1.9M | $1.6M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $1.9M | $2.8M | $11.5M | $15.7M | $11.6M | $18.2M | $23.0M |
| Deuda a Largo | 0 | $1.7M | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.9M | $4.5M | $26.2M | $32.8M | $26.6M | $32.5M | $25.4M |
| Reservas | -$135.6M | -$172.2M | -$267.2M | -$399.7M | -$495.6M | -$596.6M | -$698.0M |
| Patrimonio Neto | $35.5M | $36.1M | $477.0M | $358.7M | $271.6M | $215.4M | $220.2M |
| Deuda Total | 0 | $1.7M | $8.1M | $17.4M | $15.3M | $12.9M | $4.2M |
| Deuda Neta | -$32.9M | -$35.2M | -$463.2M | -$333.9M | -$242.4M | -$196.7M | -$158.7M |
| Capital Circulante | $31.9M | $35.1M | $465.6M | $342.5M | $254.7M | $199.8M | $152.8M |
Flujo de Caja (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$35.8M | -$36.6M | -$95.0M | -$132.4M | -$96.0M | -$101.0M | -$101.3M |
| Amortizaciones | $780000 | $894000 | $1.0M | $2.6M | $4.2M | $4.6M | $4.5M |
| Compensación en Acciones | $2.7M | $1.9M | $24.9M | $11.2M | $8.5M | $8.9M | $10.8M |
| Cambio en Capital Circulante | $1.1M | $1.2M | $1.5M | $3.1M | -$3.2M | $4.6M | -$4.6M |
| Flujo de Caja Operativo | -$30.7M | -$32.6M | -$66.8M | -$90.6M | -$94.0M | -$87.8M | -$94.7M |
| Inversiones (CapEx) | -$1.2M | -$461000 | -$5.8M | -$10.7M | -$5.3M | -$4.6M | -$2.5M |
| Adquisiciones | 0 | 0 | -$4.6M | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$31.9M | -$33.0M | -$72.6M | -$101.3M | -$99.3M | -$92.4M | -$97.2M |
Crecimiento y Márgenes (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +182.6% | -20.3% | |||||
| Crecimiento Beneficio Neto (anual) | -2.3% | -159.4% | -39.4% | +27.5% | -5.3% | -0.3% | |
| Crecimiento BPA (anual) | -2519.2% | +82.5% | +20.2% | +28.4% | -4.4% | +28.2% | |
| Cambio en Acciones (anual) | -96.1% | +1379.6% | +75.0% | +1.5% | +1.3% | +38.1% | |
| Crecimiento FCF (anual) | -3.4% | -119.7% | -39.6% | +2.0% | +7.0% | -5.3% | |
| Margen Bruto | 45.1% | 52.3% | 47.3% | ||||
| Margen Operativo | -10274.6% | -3550.6% | -3996.7% | ||||
| Margen EBITDA | -8484.7% | -3150.8% | -3813.9% | ||||
| Margen Neto | -8868.8% | -3303.0% | -4160.1% | ||||
| Margen FCF | -9178.3% | -3020.9% | -3991.5% | ||||
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.1% | -0.1% |
Datos por Acción (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| FCF por Acción | $-0.23 | $-6.14 | $-0.91 | $-0.73 | $-0.70 | $-0.65 | $-0.49 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $136.4M | $5.4M | $79.6M | $139.3M | $141.3M | $143.2M | $197.8M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -47.12% |
| Rentabilidad sobre capital invertido | -51.82% |
| Rentabilidad sobre activos | -50.89% |
| Margen bruto | 35.02% |
| Margen operativo | -5929.72% |
| Margen neto | -6138.26% |
Salud financiera
| Deuda / Patrimonio | 0.02 |
| Ratio corriente | 9.97 |
| Piotroski F-Score | 1 |
| Altman Z-Score | 0.61 |
Ratios Clave (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| P/E | -38.00 | -1.49 | -6.61 | -1.93 | -2.96 | -3.80 | -2.16 |
| P/VC | 38.01 | 1.51 | 1.31 | 0.71 | 1.05 | 1.79 | 0.99 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 262.49 | 126.43 | 89.30 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 45.1% | 52.3% | 47.3% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | -10274.6% | -3550.6% | -3996.7% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | -8868.8% | -3303.0% | -4160.1% |
Empresas relacionadas: ADCT · ALT · ANNX · AURA · AUTL · DBVT · ENGN
Explorar sector: Healthcare · Medical - Devices
Más secciones de QSI: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones